… cancer. In this review, we will examine the treatments for gastric cancer including up-to-date
molecularly targeted therapies … We will then review the molecular subtypes of gastric cancer …

… with CC develop early metastases of the main tumor, resulting in poor therapeutic and
prognosis outcomes [7]. A molecule-targeted therapy for CC has evolved in recent years. …

… of our current understanding of the molecular pathogenesis of CCA and (b) discuss present
and future directions in the implementation of targeted therapies in CCA management. …

Bladder cancer (BC) is the 11th most popular cancer in females and 4th in males. A lot of
efforts have been exerted to improve BC patients' care. Besides, new approaches have been …

Intrahepatic cholangiocarcinoma (iCCA) is a molecularly heterogeneous hepatobiliary
neoplasm with poor prognosis and limited therapeutic options. The incidence of this neoplasm is …

… Understanding the complexity of CSCs may facilitate the development of targeted therapeutic
drugs against cancer. Taken together, the major targets mentioned in this review highlight …

Globally, esophageal cancer (EC) is the 6th leading cause of cancer-related deaths and the
second deadliest gastrointestinal cancer. Multiple genetic and epigenetic factors, such as …

… of resistance to currently available targeted therapies have posed the obstacle in the …
pathogenesis more comprehensively, which might lead to more substantial progress in therapeutic …

… Interplay among immune activation and cancer pathogenesis provides the framework for
a novel subspecialty known as immunooncology. In the rapidly evolving field of …

… tumors, and the targeted therapy of cancer stem cells is an important measure for future
development. However, there is currently no drug that can be used clinically to target Bmi-1 …